Trp64Arg mutation of β3-adrenergic receptor in essential hypertension. Insulin resistance and the adrenergic system

American Journal of Hypertension

Volumn 10, Issue 1, 1997, Pages 101-105

  Fujisawa, Tomomi ^a   Ikegami, Hiroshi ^a   Yamato, Eiji ^a   Hamada, Yoichi ^a   Kamide, Kei ^a   Rakugi, Hiromi ^a   Higaki, Jitsuo ^a   Murakami, Hideyuki ^b   Shimamoto, Kazuaki ^b   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

3 adrenergic receptor; essential hypertension; genetic predisposition; insulin resistance; missense mutation

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; ARGININE; BETA ADRENERGIC RECEPTOR; TRYPTOPHAN;

ADRENERGIC ACTIVITY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; DISEASE PREDISPOSITION; GENETICS; HYPERTENSION; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY;

ADULT; AGED; ARGININE; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUTATION; RECEPTORS, ADRENERGIC, BETA; TRYPTOPHAN;

EID: 0030614767     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00297-X     Document Type: Article

References (21)

1. Lifton RP. Genetic determinants of human hypertension. Proc Natl Acad Sci USA. 92:1995;8545-8551.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
3. Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Diabetes Care. 14:1991;195-202.
4. Carmelli D, Cardon LR, Fabsitz R. Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments? Am J Hum Genet. 55:1994;566-573.
5. Ferrari P, Weidmann P, Shaw S, Giachino D. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med. 91:1991;589-596.
6. Nakagawa M, Shimamoto K, Masuda A, et al. The effect of body fat composition and family history of hypertension on insulin resistance. J Hypertens. 10:((suppl 4)):1992;s88.
7. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 71:1992;169-180.
8. Kamitani A, Rakugi H, Higaki J, et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens. 8:1994;521-524.
9. Giacobino JP. Beta 3-adrenoceptor: an update. Eur J Endocrinol. 132:1995;377-385.
10. Lowel BB, Flier JS. The potential significance of β3 -adrenergic receptors. J Clin Invest. 95:1995;923.
11. Walston J, Silver K, Bogardus C, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3 -adrenergic-receptor gene. N Engl J Med. 333:1995;343-347.
12. Widén E, Lehto M, Kanninen T, et al. Association of a polymorphism in the β3 -adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 333:1995;348-351.
13. Clément K, Vaisse C, Manning BSJ, et al. Genetic variation in the β3 -adrenergic-receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med. 333:1995;352-354.
14. Rowe JW, Young JB, Minaker KL, et al. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:1981;219-225.
15. Morris AD, Petrie JR, Connel JMC. Insulin and hypertension. J Hypertens. 12:1994;633-642.
16. Fujisawa T, Ikegami H, Yamato E, et al. Association of Trp64Arg mutation of the β3 -adrenergic-receptor with NIDDM and body weight gain. Diabetologia. 39:1996;349-352.
17. DeFronzo RJ, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:1979;E214-E233.
18. Kadowaki H, Yasuda K, Iwamoto K, et al. A mutation in the β3 -adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun. 215:1995;555-560.
19. Lockette W, Ghosh S, Farrow S, et al. α-2 Adrenergic receptor gene polymorphism and hypertension in blacks. Am J Hypertens. 8:1995;390-394.
20. Arner P. The β3 -adrenergic receptor: a cause and cure of obesity? N Engl J Med. 333:1995;382-383.
21. Bakris GL. Pathogenesis of hypertension in diabetes. Diabetes Rev. 3:1995;460-476.